|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/36 | |
| A61K 38/37 | |||
| A61K 47/36 | |||
| A61P 7/04 | |||
| A61K 47/42 | |||
| A61K 9/00 |
| (11) | Number of the document | 2768522 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12777895.9 |
| Date of filing the European patent application | 2012-10-18 | |
| (97) | Date of publication of the European application | 2014-08-27 |
| (45) | Date of publication and mention of the grant of the patent | 2016-07-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2012/070615 |
| Date | 2012-10-18 |
| (87) | Number | WO 2013/057167 |
| Date | 2013-04-25 |
| (30) | Number | Date | Country code |
| 11185648 | 2011-10-18 | EP | |
| 201161548606 P | 2011-10-18 | US |
| (72) |
METZNER, Hubert., DE
ZOLLNER, Sabine., CH
|
| (73) |
CSL Behring GmbH,
Emil-von-Behring-Strasse 76, 35041 Marburg,
DE
|
| (54) | USE OF SULFATED GLYCOSAMINOGLYCANS FOR IMPROVING THE BIOAVAILABILITY OF FACTOR VIII |
| USE OF SULFATED GLYCOSAMINOGLYCANS FOR IMPROVING THE BIOAVAILABILITY OF FACTOR VIII |